Approval · Notice of Compliance 32899 · 2024
BEYFORTUS: Notice of Compliance 32899
Issued March 14, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32899
- Date
- March 14, 2024
- Company
- Sanofi Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative ¿ Change to DIN owner.
Products in this notice
Medicinal ingredients
- NIRSEVIMAB 50 MG per 0.5ML
- NIRSEVIMAB 100 MG per ML